
结论很直接:这个市场不值得进入,已经接近价格战区,新品牌切入难度高,小商家不建议进。 现有数据里真正跑出来的只有 Moonwater Elixirs,其他新品牌 EROSMILE 的 3 个新产品全部亏损;市场不是在变好,而是在变拥挤。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这不是一个适合进入的市场。 当前样本里新品牌只有 Moonwater Elixirs 和 EROSMILE 两个,但新品牌新品盈利率只有20%,而且 EROSMILE 的新上架3个产品全部亏损,说明新进入者成功率很低;同时市场整体可识别利润产品只有35.29%,新产品利润区间集中在20%~30%,但很多产品被归入“其他”且新品牌表现极不稳定,说明靠普通跟随打法很难赚钱。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,已经明显偏饱和,价格战风险高。 新品牌里只有 1 个真正跑出来(Moonwater Elixirs 的 B0FV2XJVCN,25.9% 利润率,52 条评价,早期投入约 4,657.84 美元),但另一家新品牌 EROSMILE 3 个新品全亏,且新品牌新品盈利率只有 20%,新品牌新品失败率高达 60%;同时市场里大量老牌靠品牌力和同款竞争占位,说明不是普通小卖家友好的赛道。
结论很明确:这个市场不值得进入。 新品牌真正能跑通的样本只有 Moonwater Elixirs 这一个,EROSMILE 3 个新品全军覆没;同时新产品利润带里只有 1 个落在 20%~30%,其余 80% 都在“其他”或无法确认,说明不是稳定赚钱盘,而是高度依赖单品、流量和品牌势能的局部机会。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B096ZH6QJ1 | Aromafume | 2019-09-22 | Yes | $18.98 | 100pcs | $1898.0 | 30.46% | $578.14 |
![]() | B07Y6KNVT3 | Aromafume | 2019-09-21 | Yes | $18.99 | 50pcs | $949.5 | 30.65% | $291.03 |
![]() | B0FV2XJVCN | Moonwater Elixirs | 2025-10-07 | Yes | $17.07 | 50pcs | $853.5 | 25.88% | $220.89 |
![]() | B0DWT7WQ9J | Soul Sticks | 2025-02-11 | Yes | $12.92 | 50pcs | $646.0 | 20.54% | $132.69 |
![]() | B091G6N2WK | Soul Sticks | 2021-05-13 | Yes | $12.82 | 50pcs | $641.0 | 20.51% | $131.47 |
![]() | B091G1HRS2 | Soul Sticks | 2021-03-31 | Yes | $12.98 | 50pcs | $649.0 | 18.73% | $121.56 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FV2XJVCN | Moonwater Elixirs | 2025-10-07 | Yes | $17.07 | 50pcs | $853.5 | 25.88% | $220.89 |
这个市场不适合进入,整体已经接近价格战区,新品牌成功率很低。 现有数据里,新品盈利率只有35.29%,而新发布产品的盈利率只有20.00%;更关键的是,新品牌新发布产品里,盈利的几乎只有 Moonwater Elixirs 一家,EROSMILE 则是0%成功,说明新人不是“有机会”,而是已经被少数强势打法和同质化竞争压住了。
大品牌还能进,但要按成熟品牌逻辑重投入;小品牌想合法切入,难度很高。 代表性赢家几乎都来自老牌:Aromafume、Soul Sticks、BALIPURA 这类老品牌产品中,能盈利的多是 12.82~18.99 美元价位的无烟净化喷雾,且依赖“旧ASIN基础上的新释放”或功能微创新,而不是全新概念;像 Soul Sticks 的 B091G1HRS2、B091G6N2WK、B0DWT7WQ9J 都在 641~649 美元月收入区间,说明老牌能靠品牌力和既有认知稳住销量。反过来看,EROSMILE 的 3 个新产品全部不盈利,单品 B0FN3X1M6K 只有 14 美元左右售价、月收入 703.50 美元,但早期投入已到 1846.05 美元,仍然没转正,属于典型“卖得动但赚不到钱”。
小商家如果想做,必须找到真正差异化,否则就是继续烧钱。 唯一像样的新品牌成功是 Moonwater Elixirs 的 B0FV2XJVCN:17.07 美元定价,靠 Palo Santo + Reiki Charged + clear quartz 的组合叙事、无烟、便携、冥想/空间净化场景,才拿到盈利;但它也不是轻装上阵,市场投资建议的最低落地资金直接是约 900.97 美元,而像 EROSMILE 这种同类产品不但没有形成差异,还落在“LACK_OF_UNIQUENESS + SMALL_MARKET_SIZE_OR_EXTREME_COMPETITION + GOOD_BUT_LOW_PROFIT_MARGIN”里。再看趋势,2025 年新发布产品是 1 盈利、3 不盈利,2026 年继续只有未确认成功的新品,说明新增并没有把市场推向更健康的增长,反而是在加剧拥挤。结论很直接:大品牌可进但要重投入,小商家不建议进;若硬要做,只能复制 Moonwater Elixirs 这类强差异化路径,普通白鼠尾草/能量净化喷雾不要碰。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
结论很明确:这个市场不适合现在进入。 近端新品牌成功率只有20%,但真正的新品牌新上架产品里,只有1个成功、3个失败,胜率只有25%;同时月度样本里可识别利润的产品只有35.29%盈利,说明竞争已经在向低利润挤压,且不是一个适合小品牌轻松切入的赛道。
证据很直接:市场时间上几乎没有明显的扩张信号,2025年只有少量新品牌动作,最近几个月也只有 Moonwater Elixirs 的 B0FV2XJVCN 跑出结果,而 EROSMILE 的 3 个新上架 ASIN(B0FN3XT9ZD、B0FN3X1M6K、B0FN3XBF9J)全部失败,显示新进入者要么没有打穿,要么需要更重的投放和运营。B0FV2XJVCN 本身虽然做到了 25.9% 利润率、近月销售 50 单、月营收 853.50 美元,但它的早期投入达到 4657.84 美元,其中广告 1047.55 美元,说明“成功”不是低预算就能复制的。Moonwater Elixirs 目前只有 2 个产品、1 个可识别盈利、1 个利润未明,品牌级成功率看起来高,但样本太小,不能当作普通小商家的稳定案例;更关键的是,B0FV2XJVCN 52 条评论对应 12 个月内 116 单的起步表现,仍属正常白帽路径,不是那种靠 200-300+ 评论/年硬推出来的异常盘,但它已经明显需要中等以上启动资金和持续投放。
最终判断:不要进。 大品牌如果硬要进,必须准备至少接近这类成功样本的投放强度与更高的长期品牌/R&D预算;小商家更不应该进,因为市场里目前没有足够多“真正小而美”的持续成功样本,反而失败样本更集中。可参考的案例只有 Moonwater Elixirs 的 B0FV2XJVCN;应重点回避 EROSMILE 的 B0FN3XT9ZD、B0FN3X1M6K、B0FN3XBF9J。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 3 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |